Contents of Tocriset:
|Cat.No.||Product Name / Activity|
|cell-permeable activator of adenylyl cylcase|
|1140||8-Bromo-cAMP, sodium salt|
|cell-permeable cAMP analogue; PKA activator|
|potent, selective inhibitor of PKA|
|water-soluble analogue of forskolin; activator of adenylyl cyclase|
|2910||H 89 dihydrochloride|
|protein kinase A inhibitor|
Contains the listed products which can be used to modulate PKA signalling. The products are supplied as lyophilised solids or pre-dissolved in 0.5 ml DMSO at various stock concentrations.
Tocrisets contain 3-5 ligands supplied as lyophilized solids or pre-dissolved in DMSO at a specified concentration. Lyophilized solids have been freeze-dried (approximately 0.5-2 mg per vial) so that addition of 0.5 or 1 ml of solvent produces a stock concentration of 10 or 5 mM respectively.
Please see individual product listings for specific technical data and certificate of analysis.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
References are publications that support the products' biological activity.
If you know of a relevant reference for PKA Tocriset™, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: PKA Tocriset ligand sets Protein Kinase A
Citations for PKA Tocriset™
Citations are publications that use Tocris products.
Currently there are no citations for PKA Tocriset™. Do you know of a great paper that uses PKA Tocriset™ from Tocris? If so please let us know.